The mixed cluster suggests divergent views on ABBV ahead of strong earnings and a large acquisition. Monitor next quarter's 13F for whether the buyers (especially Assenagon) increased further post-earnings, and watch for any insider buying to corroborate institutional conviction. The Apogee deal's dilutive impact on EPS guidance may keep sentiment balanced in the near term.
ABBV drugs
ABBV drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 3 $245.10entry
- T+1 · 4mo ago −0.53%α −2.33% · $243.80
- T+5 · 3mo ago +1.17%α −0.86% · $247.97
- T+20 · 3mo ago +4.62%α +3.38% · $256.42
- T+60 · 21d ago +17.08%α +15.30% · $286.97
How similar events traded
Executive Summary
In Q2 2026, three institutional buyers added $270.2M to ABBV positions while three sellers trimmed $149.4M, resulting in a net accumulation of $120.8M. The cluster is mixed in direction, with the largest buyer (Assenagon) adding $234.5M and the largest seller (Artemis) trimming $105.1M. This positioning occurred ahead of AbbVie's strong Q2 earnings beat and the $10.9B Apogee acquisition announced on July 31, suggesting some funds anticipated positive results while others took profits or reduced exposure.
Key Financial Metrics
Institutional Positions
Net institutional flow: $120.8M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | ADD | +55.5% | $527.9M | $234.5M |
| Banco Santander | ADD | +34.1% | $46.8M | $16.6M |
| Exchange Traded Concepts | DOUBLED | +204.3% | $26.6M | $19.0M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Artemis Investment Management | TRIM | -53.7% | $226.5M | -$105.1M |
| Td Waterhouse Canada | TRIM | -27.2% | $107.9M | -$15.9M |
| Op Asset Management | TRIM | -36.5% | $78.2M | -$28.5M |
Key Facts
- Net institutional accumulation of $120.8M in Q2 2026 (3 buyers adding $270.2M, 3 sellers trimming $149.4M)
- Largest buyer: Assenagon Asset Management added $234.5M (+55.5% to $527.9M)
- Largest seller: Artemis Investment Management trimmed $105.1M (-53.7% to $121.4M)
- Exchange Traded Concepts doubled its position (+204.3% to $26.6M)
- Cluster occurred ahead of AbbVie's Q2 2026 earnings beat (EPS $3.65 vs $3.61 consensus) and $10.9B Apogee acquisition announcement
Financial Impact
Net institutional buying of $120.8M, representing ~0.03% of ABBV's $443.4B market cap; buying totaled $270.2M, selling totaled $149.4M
Risk Factors
- 13F data is 45 days stale; positions may have been unwound since quarter-end
- Net buying is very small relative to market cap, limiting price impact
- Mixed direction (3 buyers vs 3 sellers) reduces signal clarity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ABBV-2026-Q2 |
Track record
22 reports on ABBV
7 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +27.21% at T+60 after the Apr 29, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $293.89 settles Dec 9
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $286.00 settles Dec 2
- Oct 30, 202617d ago 8-K Bullish 6/10 Entry $294.89 settles Nov 30
- Oct 29, 202619d ago Court Ruling Bullish 7/10 Entry $294.89 settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $282.68 to $294.55 ▲ +4.20% +7.66% vs SPY
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $285.42 to $295.03 ▲ +3.37% +4.53% vs SPY
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $265.06 to $289.60 ▲ +9.26% +12.16% vs SPY
- Sep 28, 20267w ago Court Ruling Neutral 2/10 Entry $263.29 to $286.39 ▲ +8.77% +8.06% vs SPY
- Sep 14, 20269w ago Court Ruling Neutral Not scored Entry $261.43 to $272.69 ▲ +4.30% +1.33% vs SPY
- Sep 3, 202610w ago 8-K Neutral 4/10 Entry $260.21 to $262.82 ▲ +1.00% +2.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers